Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies
O Lyass, A Hubert, A A Gabizon
Anti-Cancer Drugs
|
May 2, 2000
Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
A Hubert, O Lyass, D Pode, et al.
Anti-Cancer Drugs
|
March 10, 1998
Cisplatin-induced non-convulsive encephalopathy
O Lyass, A Lossos, A Hubert, et al.
Cancer
|
May 20, 1998
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
B Nisman, J Lafair, N Heching, et al.
Cancer
|
July 3, 1999
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
Z Symon, A Peyser, D Tzemach, et al.
Anticancer Research
|
January 12, 2000
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
B Nisman, G Amir, J Lafair, et al.
European Journal of Gynaecological Oncology
|
January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature
O Lyass, G Brufman, D Z Edelmann, et al.
Archives of Dermatology
|
December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin
M Lotem, A Hubert, O Lyass, et al.
International Journal of Oncology
|
May 5, 2011
Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable port
S Lyass, O Lyass, A Gabizon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy
M J Zelefsky, O Lyass, Z Fuks, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies
O Lyass, A Hubert, A A Gabizon
Anti-Cancer Drugs
|
May 2, 2000
Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
A Hubert, O Lyass, D Pode, et al.
Anti-Cancer Drugs
|
March 10, 1998
Cisplatin-induced non-convulsive encephalopathy
O Lyass, A Lossos, A Hubert, et al.
Cancer
|
May 20, 1998
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
B Nisman, J Lafair, N Heching, et al.
Cancer
|
July 3, 1999
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
Z Symon, A Peyser, D Tzemach, et al.
Anticancer Research
|
January 12, 2000
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
B Nisman, G Amir, J Lafair, et al.
European Journal of Gynaecological Oncology
|
January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature
O Lyass, G Brufman, D Z Edelmann, et al.
Archives of Dermatology
|
December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin
M Lotem, A Hubert, O Lyass, et al.
International Journal of Oncology
|
May 5, 2011
Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable port
S Lyass, O Lyass, A Gabizon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy
M J Zelefsky, O Lyass, Z Fuks, et al.
Page
of 2